DS
LEGN icon

David Shaw’s Legend Biotech LEGN Stock Holding History

David Shaw’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-40,922
Closed -$2.3M – 4675
2024
Q1 		$2.3M Sell
40,922
-129,207
-76% -$7.79M ﹤0.01% 2525
2023
Q4 		$10.2M Sell
170,129
-16,007
-9% -$1.01M 0.01% 1344
2023
Q3 		$12.5M Sell
186,136
-79,029
-30% -$5.49M 0.01% 1125
2023
Q2 		$18.3M Buy
265,165
+144,597
+120% +$9.45M 0.02% 927
2023
Q1 		$5.81M Sell
120,568
-282,429
-70% -$13.8M 0.01% 1808
2022
Q4 		$20.1M Sell
402,997
-110,392
-22% -$5.35M 0.02% 919
2022
Q3 		$20.9M Buy
513,389
+389,499
+314% +$18.3M 0.03% 816
2022
Q2 		$6.81M Sell
123,890
-241,032
-66% -$10.2M 0.01% 1774
2022
Q1 		$13.3M Sell
364,922
-68,174
-16% -$2.69M 0.01% 1347
2021
Q4 		$20.2M Buy
433,096
+112,787
+35% +$5.72M 0.02% 1085
2021
Q3 		$16.2M Buy
320,309
+122,796
+62% +$5.11M 0.01% 1156
2021
Q2 		$8.11M Buy
+197,513
New +$6.71M 0.01% 1675

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

David Shaw's LEGN Position: Q2 2024 in Review

David Shaw sold out of Legend Biotech (LEGN) in Q2 2024, closing a stake of 40,922 shares — an estimated $2.3M sold.

David Shaw first reported a position in LEGN in Q2 2021 and held it in 12 quarters. The position peaked at $20.9M in Q3 2022. 181 funds tracked by Wall St. Rank hold LEGN as of Q2 2024.

  • David Shaw reported no remaining Legend Biotech position as of Q2 2024 after selling out during the quarter.
  • David Shaw sold 40,922 Legend Biotech shares in Q2 2024, an estimated $2.3M.
  • David Shaw first reported a position in Legend Biotech in Q2 2021 and held it in 12 quarters.
  • David Shaw's Legend Biotech position peaked at $20.9M in Q3 2022.
  • 181 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2024.

Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.